SPL RF Jan 2021

EN_01459393_0317

30,00 EUR Private use
Making print for private purpose, storage in computer memory, no distribution rights.
40,00 EUR Internet - private use
Strictly for editorial, single use on a personal (nonprofit) web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
75,00 EUR Internet commercial use
Strictly for editorial, single use on a commercial web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
90,00 EUR Print use
Strictly for editorial, single use, inside of newspaper, magazine, book (including digital version), one edition, one single country. Not for resale.

Gross prices

special instructions

SPECIAL RATES FOR EDITORIAL AND BOOKS RF RATES FOR OTHER USE - INTERNET +100% Internet +100%

caption

RNA vaccine, conceptual illustration. Close-up of a molecule of RNA (ribonucleic acid, blue) being injected into a patient. The first RNA vaccine approved for human use, developed against the SARS-CoV-2 coronavirus by Pfizer/BioNTech, was approved in the UK on 2nd December 2020.

headline SPL RF Jan 2021

created date 2021-01-02

credit DESIGN CELLS/Science Photo Library RF/East News

source Science Photo Library RF

byline DESIGN CELLS

original transmission reference f0325888

weight 3,49MB

size 61cm x 34cm by 300dpi

keywords - Show

1ST, ACID, ARTWORK, BIOLOGICAL, BIOLOGY, BIONTECH, BIOTECHNOLOGICAL, BIOTECHNOLOGY, BODY, CELLS, CONCEPTS, CONCEPTUAL, CONDITION, CORONAVIRUS, COVID-19, DESIGN, DISEASE, DISORDER, EPIDEMIC, FIRST, HCOV, HUMAN, ILLUSTRATION, IMMUNISATION, IMMUNISING, IMMUNITY, IMMUNIZING, INJECTING, INJECTION, MESSENGER, MRNA, NO-ONE, NOBODY, PANDEMIC, PFIZER, RIBONUCLEIC, RNA, SARS-COV, SARS-COV-2, VACCINATING, VACCINATION, VACCINE, VIRAL,